## MO: Altria Group, Inc. - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 -1.3% below STRENGTH zone (3.0-6.0%); PEG 4.01 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($56.48)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. MO Expands Smokeable Margins to 64% as Cigarette Volumes Fall 9%**
- Source: TradingView | 20251208T150827 | Bullish | Relevance: 99%
- Altria (MO) achieved significant margin expansion to 64.4% in its smokeable segment during Q3 2025, despite a 9% decline in domestic cigarette volumes. This profitability was driven by price realization, Marlboro's premium market share stability, and operational efficiencies, enabling the company to extract more profit from fewer cigarette units. The article also compares MO's performance to Philip Morris International (PM) and Turning Point Brands (TPB), highlighting similar trends in margin expansion through strategic pricing and smoke-free product innovation.

**2. Health Trends Can’t Stop This Stock and Its 7% Dividend Yield**
- Source: Barron's | 20251207T230842 | Somewhat-Bullish | Relevance: 99%
-  Altria (MO) is facing challenges due to health trends but maintains a stable 7% dividend yield. Despite its problems, the large payout can offset many concerns for investors. The company is the parent of Philip Morris.

**3. Cerity Partners LLC Purchases 153,567 Shares of Altria Group, Inc. $MO**
- Source: MarketBeat | 20251209T100559 | Somewhat-Bullish | Relevance: 99%
-  Cerity Partners LLC significantly increased its stake in Altria Group Inc. (NYSE:MO) by purchasing 153,567 shares in the second quarter, bringing its total holdings to 539,238 shares valued at $31.625 million. Other institutional investors have also adjusted their positions in Altria, with significant increases from JPMorgan Chase & Co. and Nuveen LLC. The article also provides a financial overview of Altria Group, including its recent earnings, stock performance, and analyst ratings, which currently average a "Hold" with a price target of $62.33.

**4. Health Trends Can’t Stop This Stock and Its 7% Dividend Yield**
- Source: Barron's | 20251208T011414 | Somewhat-Bullish | Relevance: 98%
- Despite facing challenges from health trends, Altria stock offers a stable 7% dividend yield that makes it an attractive investment. This high payout is seen as sufficient to offset various issues the company might encounter. The article features Altria, the parent company of Philip Morris, known for Marlboro cigarettes.

**5. Altria Group, Inc. $MO Shares Sold by Fayez Sarofim & Co**
- Source: MarketBeat | 20251209T102528 | Neutral | Relevance: 98%
-  Fayez Sarofim & Co reduced its stake in Altria Group, Inc. (NYSE:MO) by 5.1% in the second quarter, selling 292,913 shares. Despite this, other major investors like GQG Partners LLC and JPMorgan Chase & Co. significantly increased their holdings. The company recently reported quarterly earnings of $1.45 per share, surpassing analyst estimates, and announced a $2.00 billion stock repurchase plan.

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 34.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 9.5% (-0.4%)
- Blackrock Inc.: 7.5% (+2.4%)
- State Street Corpora: 4.3% (-0.9%)
- Charles Schwab Inves: 3.5% (-4.7%)
- Geode Capital Manage: 2.7% (+1.2%)

### Key Risks

1. Valuation stretched: PEG 4.0x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 4.01 signals overvaluation risk, limited margin of safety. Forward P/E 10.4x stretched relative to 3% growth. Quality metrics strong (ROA 22%, margin 44%). Balance sheet: $3.4B free cash flow. Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $97.7B |
| Beta | 0.50 |
| 52W Range | $50.08 - $68.60 |
| Short Interest | 2.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.01 |
| Forward P/E | 10.4 |
| Current P/E | 10.7 |
| YoY Growth | 2.8% |
| EPS Direction | STABLE |

### Technicals

MRS_10 improving modestly (+0.9% over 5 days). Below STRENGTH zone by 4.3pp (needs >3.0% for momentum thesis). Below SMA200 (0.96x), long-term trend not supportive. RSI neutral at 42.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.32% (CS: 44) | Neutral |
| RSI_14 | 42.2 | Neutral |
| MACD Histogram | 0.18 | Bullish |
| vs SMA20 | 0.997x | Below |
| vs SMA50 | 0.953x | Below |
| vs SMA200 | 0.960x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $58.18
- **Stop Loss:** $56.48 (2.9% risk)
- **Target:** $59.88 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 294
- **Position Value:** $17,104.92
- **Portfolio %:** 17.10%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not inverted—indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-01-29 (Est: $1.32)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.45 | $1.45 | +0.1% |
| 2025Q2 | $1.38 | $1.44 | +4.0% |
| 2025Q1 | $1.19 | $1.23 | +3.5% |
| 2024Q4 | $1.28 | $1.29 | +0.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*